These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is "Safe Better than Sorry"? Pradère B; Ploussard G; Catto JWF; Rouprêt M; Misrai V Eur Urol; 2020 Aug; 78(2):134-135. PubMed ID: 32284245 [No Abstract] [Full Text] [Related]
7. Can an Old Ally Defeat a New Enemy? Gurbel PA; Bliden KP; Schrör K Circulation; 2020 Jul; 142(4):315-317. PubMed ID: 32478567 [No Abstract] [Full Text] [Related]
8. Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection. Pathak SK; Pandey S; Pandey A; Salunke AA; Thivari P; Ratna HVK; Chawla J Diabetes Metab Syndr; 2020; 14(6):1873-1874. PubMed ID: 32998094 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 in children: analysis of the first pandemic peak in England. Ladhani SN; Amin-Chowdhury Z; Davies HG; Aiano F; Hayden I; Lacy J; Sinnathamby M; de Lusignan S; Demirjian A; Whittaker H; Andrews N; Zambon M; Hopkins S; Ramsay ME Arch Dis Child; 2020 Dec; 105(12):1180-1185. PubMed ID: 32796006 [TBL] [Abstract][Full Text] [Related]
10. Analyzing changes in respiratory rate to predict the risk of COVID-19 infection. Miller DJ; Capodilupo JV; Lastella M; Sargent C; Roach GD; Lee VH; Capodilupo ER PLoS One; 2020; 15(12):e0243693. PubMed ID: 33301493 [TBL] [Abstract][Full Text] [Related]
11. Patient-Driven Discontinuation of Apremilast During the COVID-19 Pandemic in Two Canadian Academic Hospital Clinics and One Community Practice. Georgakopoulos JR; Vender R; Yeung J J Cutan Med Surg; 2020; 24(4):418-419. PubMed ID: 32396018 [No Abstract] [Full Text] [Related]
12. COVID-19 and seizures: Is there a link? Vohora D; Jain S; Tripathi M; Potschka H Epilepsia; 2020 Sep; 61(9):1840-1853. PubMed ID: 32944929 [TBL] [Abstract][Full Text] [Related]
13. The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection? Ferrara F; Granata G; Pelliccia C; La Porta R; Vitiello A Eur J Clin Pharmacol; 2020 Nov; 76(11):1615-1618. PubMed ID: 32594204 [TBL] [Abstract][Full Text] [Related]
14. A Patient with Fever and Dyspnea. Matias WR; Vaidya A; Brigl M; Bebell LM N Engl J Med; 2020 Nov; 383(19):e111. PubMed ID: 33211933 [No Abstract] [Full Text] [Related]
15. Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era. Armesto S; González Vela C; González López MA Dermatol Ther; 2020 Jul; 33(4):e13618. PubMed ID: 32424891 [No Abstract] [Full Text] [Related]
16. COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management. Mugheddu C; Pizzatti L; Sanna S; Atzori L; Rongioletti F J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e376-e378. PubMed ID: 32385859 [No Abstract] [Full Text] [Related]
17. [Respiratory complaints in the time of COVID-19]. Loogman MCM; de Jong N; Platteel TN; Bouma M; Verheij TJM; Opstelten W Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32392007 [TBL] [Abstract][Full Text] [Related]
18. Treating COVID-19 with colchicine in community healthcare setting. Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478 [No Abstract] [Full Text] [Related]
19. COVID-19 and NSAIDs: Primum non nocere. Micallef J; Soeiro T; Jonville-Béra AP Therapie; 2020; 75(5):514-515. PubMed ID: 32839015 [No Abstract] [Full Text] [Related]
20. Ratcheting down the virulence of SARS-CoV-2 in the COVID-19 pandemic. Brufsky A; Lotze MT J Med Virol; 2020 Nov; 92(11):2379-2380. PubMed ID: 32458475 [No Abstract] [Full Text] [Related] [Next] [New Search]